Laurie D. Stelzer
2019
Compensation breakdown
| Bonus | $2,500 |
|---|---|
| Non-Equity Incentive Plan | $231,660 |
| Option Awards | $750,005 |
| Salary | $495,000 |
| Stock Awards | $750,016 |
| Other | $16,939 |
| Total | $2,246,120 |
Stelzer received $750K in stock awards, accounting for 33% of the total pay in 2019.
Stelzer also received $2.5K in bonus, $231.7K in non-equity incentive plan, $750K in option awards, $495K in salary and $16.9K in other compensation.
Rankings
In 2019, Laurie D. Stelzer's compensation ranked 5,340th out of 13,971 executives tracked by ExecPay. In other words, Stelzer earned more than 61.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,340 out of 13,971 | 62nd |
Division Manufacturing | 1,988 out of 5,695 | 65th |
Major group Chemicals And Allied Products | 702 out of 2,194 | 68th |
Industry group Drugs | 591 out of 1,880 | 69th |
Industry Biological Products, Except Diagnostic Substances | 137 out of 389 | 65th |
Pay ratio
| Laurie D. Stelzer's Pay | $2,246,120 |
|---|---|
| Median Employee's Pay | $238,096 |
| Pay Ratio | 9to 1 |
In 2019, the annual total compensation of Laurie D. Stelzer was $2,246,120.
The annual total compensation of the median employee at Halozyme Therapeutics was $238,096.
The ratio of Laurie D. Stelzer's pay to the pay of median employee was therefore 9 to one.
Stelzer's colleagues
We found four more compensation records of executives who worked with Laurie D. Stelzer at Halozyme Therapeutics in 2019.
2019
Helen Torley
Halozyme Therapeutics
Chief Executive Officer
2019
Alison Armour
Halozyme Therapeutics
Former Senior Vice President, Head of Research & Development
2019
Benjamin Hickey
Halozyme Therapeutics
Former Senior Vice President, Chief Commercial Officer
2019
Harry Leonhardt
Halozyme Therapeutics